Silexion Therapeutics Urges Shareholders to Vote Ahead of March 16 Extraordinary General Meeting March 5, 2026
Hashdex Names Bruno Caratori as Global CEO, Marcelo Sampaio as Executive Chairman and Mick McLaughlin as U.S. CEO March 5, 2026
Tangram Therapeutics Announces First Participant Dosed in Phase 1/2 RESTORE-MASH Trial of TGM-312, a Novel Investigational RNAi Medicine March 5, 2026
Quantum Leap Energy Appoints Nate Salpeter, Ph.D., a Key Opinion Leader in Fluid Dynamics and Energy Technology, as its Chief Technology Officer March 5, 2026
HawkSearch By Bridgeline Enhances eCommerce Search for Global Industrial and Medical Gas Provider March 5, 2026
Atavistik Bio Closes $40 Million Series B Extension for Advancement of its Pipeline Bringing Total Round Proceeds to $160 Million March 5, 2026